A pediatric case of secondary T-cell acute lymphoblastic leukemia with KMT2A-MAML2 developing after hepatoblastoma treatment

Pediatr Blood Cancer. 2020 Jan;67(1):e28033. doi: 10.1002/pbc.28033. Epub 2019 Oct 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Hepatoblastoma / complications*
  • Histone-Lysine N-Methyltransferase / genetics*
  • Humans
  • Infant, Newborn
  • Liver Neoplasms / complications*
  • Male
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / etiology*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Prognosis
  • Trans-Activators / genetics*

Substances

  • KMT2A protein, human
  • MAML2 protein, human
  • Oncogene Proteins, Fusion
  • Trans-Activators
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase